AI, Startups, Design
Stanford researchers will discuss their agentic AI 'scientists' that are on course to reshape drug discovery at VB Transform 2026
Stanford researchers are developing agentic AI scientists to revolutionize drug discovery by streamlining the drug development process, aiming to increase success rates and reduce costs and timelines at the VB Transform 2026 conference.